Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, reported financial results for the first quarter ended March 31, 2022 as well as certain other business highlights.
May 12, 2022
· 9 min read